Introduction to Hepatocellular Carcinoma Issue
Amit G. Singal – 3 June 2021
Erratum
3 June 2021
Beyond Survival: Targeting Health‐Related Quality of Life Outcomes After Liver Transplantation
David J. Cristin, Lisa M. Forman, Whitney E. Jackson – 3 June 2021
Developing an Evidence Base for the Delivery of Hepatitis B Virus Birth Dose Vaccination: An Evidence Map and Critical Appraisal of Systematic Reviews and Guidelines
Stephanie Doran Brubaker, John W. Ward, Lindsey Hiebert, Rebecca L. Morgan – 3 June 2021
Systemic Therapy for Hepatocellular Carcinoma
Jennifer Wang, Anjana Pillai – 3 June 2021
Killing Two Birds With No Stone
Jane Giang, Dawn S. Harrison, Benjamin K. Hansen, Michael W. Fried, Jama M. Darling – 3 June 2021
Radiation Therapies for the Treatment of Hepatocellular Carcinoma
Neehar D. Parikh, Kyle Cuneo, Mishal Mendiratta‐Lala – 3 June 2021
Classic Autoimmune Liver Disorders and Celiac Hepatitis
Muhammad Amir, Samir M. Parekh – 3 June 2021
Acute Liver Failure Etiology Is an Independent Predictor of Waitlist Outcome but Not Posttransplantation Survival in a National Cohort
Natalie Z. Wong, K. Rajender Reddy, Therese Bittermann – 2 June 2021 – The impact of acute liver failure (ALF) etiology on waitlist (WL) and posttransplantation outcomes, independent of severity of illness, is incompletely characterized. All adults (n = 1691) listed for primary liver transplantation (LT) between 2002 and 2019 with ALF due to acetaminophen toxicity (APAP), drug‐induced liver injury (DILI), autoimmune hepatitis (AIH), and hepatitis B virus (HBV) were identified in the United Network for Organ Sharing database.